- Home
- TGTX
TGTX
TG Therapeutics Inc.
as 04-04-2025 4:00pm EST
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $40.67 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.15 | EPS Growth: | 68.03 |
| 52 Week Low/High: | $12.93 - $43.32 | Next Earning Date: | 04-30-2025 |
| Revenue: | $329,004,000 | Revenue Growth: | 40.80% |
| Revenue Growth (this year): | 75.63% | Revenue Growth (next year): | 38.07% |
Latest TG Therapeutics Inc. News
TGTX Breaking Stock News: Dive into TGTX Ticker-Specific Updates for Smart Investing
Investor's Business Daily
3 days ago
IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche
Argus Research
4 days ago
TGTX: Lowering target price to $40.00
Simply Wall St.
6 days ago
Should We Be Cautious About TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE Of 11%?
Argus Research
11 days ago
TGTX: Raising target price to $45.00
Investor's Business Daily
15 days ago
These Insurance Stocks And Biotech Leader Hit New Highs As Stock Market Crumbles
Insider Monkey
17 days ago
TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts
Zacks
19 days ago
Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?
Insider Monkey
22 days ago
Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025?
Compare TGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TGTX TG Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.